Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1978 Sep;33(3):377–385.

The role of antibody in the inhibition of the growth of Meth.A tumour in syngeneic experiments in vivo and in vitro.

E Farram, H Festenstein, L de Giorgi
PMCID: PMC1537444  PMID: 737892

Abstract

An in vitro technique for detecting anti-tumour responses was studied and shown to involve non- T cells. Further examination of the effector mechanism revealed that tumour inhibition was antibody mediated, probably through complement dependent lysis; ADCC was considered unlikely. The amount of antibody involved was small, as shown by indirect immunofluorescence labelling of tumour cells, but was nevertheless effective in vitro and in causing regression of tumours in vivo. These findings may have important implications for the manipulation of the host responses to tumours.

Full text

PDF
385

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bansal S. C., Hargreaves R., Sjögren H. O. Facilitation of polyoma tumor growth in rats by blocking sera and tumor eluate. Int J Cancer. 1972 Jan 15;9(1):97–108. doi: 10.1002/ijc.2910090112. [DOI] [PubMed] [Google Scholar]
  2. Chia E., Festenstein H. Specific cytostatic effect of lymph node cells from normal and T cell-deficient mice on syngeneic tumor target cells in vitro and its specific abrogation by body fluids from syngeneic tumor-bearing mice. Eur J Immunol. 1973 Aug;3(8):483–487. doi: 10.1002/eji.1830030806. [DOI] [PubMed] [Google Scholar]
  3. Fernbach B. R., Kirchner H., Herberman R. B. Inhibition of the mixed lymphocyte culture by peritoneal exudate cells. Cell Immunol. 1976 Mar 15;22(2):399–403. doi: 10.1016/0008-8749(76)90043-5. [DOI] [PubMed] [Google Scholar]
  4. Greenberg A. H., Shen L., Medley G. Characteristics of the effector cells mediating cytotoxicity against antibody-coated target cells. I. Phagocytic and non-phagocytic effector cell activity against erythrocyte and tumour target cells in a 51Cr release cytotoxicity assay and [125I]IUdR growth inhibition assay. Immunology. 1975 Oct;29(4):719–729. [PMC free article] [PubMed] [Google Scholar]
  5. Hellström K. E., Hellström I. Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens. Adv Immunol. 1974;18:209–277. doi: 10.1016/s0065-2776(08)60311-9. [DOI] [PubMed] [Google Scholar]
  6. Julius M. H., Simpson E., Herzenberg L. A. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol. 1973 Oct;3(10):645–649. doi: 10.1002/eji.1830031011. [DOI] [PubMed] [Google Scholar]
  7. Lamon E. W., Hale P., Whitten H. D. Antibody-dependent, cell-mediated cytotoxicity with autochthonous lymphocytes and sera after infection with Moloney sarcoma virus. J Natl Cancer Inst. 1976 Feb;56(2):349–355. doi: 10.1093/jnci/56.2.349. [DOI] [PubMed] [Google Scholar]
  8. MacLennan I. C., Loewi G., Harding B. The role of immunoglobulins in lymphocyte-mediated cell damage, in vitro. I. Comparison of the effects of target cell specific antibody and normal serum factors on cellular damage by immune and non-immune lymphocytes. Immunology. 1970 Mar;18(3):397–404. [PMC free article] [PubMed] [Google Scholar]
  9. Old L. J., Boyse E. A., Geering G., Oettgen H. F. Serologic approaches to the study of cancer in animals and in man. Cancer Res. 1968 Jul;28(7):1288–1299. [PubMed] [Google Scholar]
  10. Pollack S., Heppner G., Brawn R. J., Nelson K. Specific killing of tumor cells in vitro in the presence of normal lymphoid cells and sera from hosts immune to the tumor antigens. Int J Cancer. 1972 Mar 15;9(2):316–323. doi: 10.1002/ijc.2910090209. [DOI] [PubMed] [Google Scholar]
  11. Rouse B. T., Grewal A. S., Babiuk L. A. Complement enhances antiviral antibody-dependent cell cytotoxicity. Nature. 1977 Mar 31;266(5601):456–458. doi: 10.1038/266456a0. [DOI] [PubMed] [Google Scholar]
  12. Schirrmacher V., Halloran P., Ross E., Festenstein H. A new sensitive assay for antibody against cell surface antigens based on inhibition of cell-dependent antibody-mediated cutotoxicity. II. Mechanism. Cell Immunol. 1975 Apr;16(2):362–373. doi: 10.1016/0008-8749(75)90124-0. [DOI] [PubMed] [Google Scholar]
  13. Senik A., de Giorgi L., Gomard E., Levy J. P. Cytostasis of lymphoma cells in suspension: probable non-thymic origin of the cytostatic lymphoid cells in mice bearing mys -induced tumors. Int J Cancer. 1974 Sep 15;14(3):396–400. doi: 10.1002/ijc.2910140314. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES